substance p, sar(9)-met(o2)(11)- has been researched along with 3-nitrotyrosine in 1 studies
| Studies (substance p, sar(9)-met(o2)(11)-) | Trials (substance p, sar(9)-met(o2)(11)-) | Recent Studies (post-2010) (substance p, sar(9)-met(o2)(11)-) | Studies (3-nitrotyrosine) | Trials (3-nitrotyrosine) | Recent Studies (post-2010) (3-nitrotyrosine) |
|---|---|---|---|---|---|
| 151 | 0 | 6 | 3,510 | 87 | 1,137 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, SF; Angulo, JA; Wang, J; Xu, W; Zhu, J | 1 |
1 other study(ies) available for substance p, sar(9)-met(o2)(11)- and 3-nitrotyrosine
| Article | Year |
|---|---|
The neurokinin-1 receptor modulates the methamphetamine-induced striatal apoptosis and nitric oxide formation in mice.
Topics: Analysis of Variance; Androstanes; Animals; Apoptosis; Benzimidazoles; Body Temperature; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Corpus Striatum; Dose-Response Relationship, Drug; Drug Combinations; Electrochemistry; Immunotoxins; In Situ Nick-End Labeling; Male; Methamphetamine; Mice; Mice, Inbred ICR; Microinjections; Nerve Tissue Proteins; Neurokinin-1 Receptor Antagonists; Nitric Oxide; Receptors, Neurokinin-1; Ribosome Inactivating Proteins, Type 1; Saporins; Substance P; Tyrosine | 2009 |